ArticleFrontiers in medicine2026
Evolution of the NCI antibody-drug conjugate portfolio: from chemical engineering to clinical complexity.
Qiang Zhan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it